Go Deep
Eli Lilly and Company
Eli Lilly and Company Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 4,077 | 38.3 | 30.08 | 1.62 | 109,927.18 |
| Oct 2026 | 4,077 | 38.4 | 30.08 | 1.62 | 109,915.89 |
| Oct 2026 | 4,077 | 38.4 | 30.08 | 1.62 | 109,915.89 |
| Oct 2026 | 4,073 | 38.4 | 30.09 | 1.62 | 109,941.85 |
| Oct 2026 | 4,077 | 38.9 | 30.47 | 1.62 | 111,602.94 |
| Oct 2026 | 4,078 | 38.4 | 30.47 | 1.62 | 111,602.94 |
| Oct 2026 | 3,545 | 39.9 | 31.29 | 1.62 | 114,754.05 |
| Oct 2026 | 3,821 | 39.3 | 30.79 | 1.62 | 112,908.29 |
| Oct 2026 | 3,406 | 39.6 | 31.04 | 1.62 | 114,101.92 |
| Oct 2026 | 3,297 | 39.7 | 31.13 | 1.62 | 113,224.67 |
| Oct 2026 | 4,382 | 39.2 | 30.70 | 1.62 | 111,091.06 |
| Oct 2026 | 3,662 | 40.6 | 31.82 | 1.62 | 114,766.84 |
| Oct 2026 | 2,932 | 40.5 | 32.94 | 1.62 | 118,854.19 |
| Oct 2026 | 2,838 | 42.2 | 33.09 | 1.62 | 119,059.54 |
| Oct 2026 | 3,123 | 41.6 | 32.65 | 1.62 | 117,604.56 |
| Oct 2026 | 2,456 | 43.1 | 33.79 | 1.62 | 121,712.00 |
| Oct 2026 | 2,675 | 42.7 | 33.45 | 1.62 | 120,190.29 |
| Oct 2026 | 2,100 | 43.9 | 34.39 | 1.62 | 123,339.54 |
Eli Lilly and Company Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 22,974,000,000.0 | 19,799,000,000.0 | 19,292,000,000.0 | 17,600,800,000.0 |
| Net Profit | 7,095,000,000.0 | 7,396,000,000.0 | 6,637,700,000.0 | 5,582,500,000.0 |
| EPS | 8.0 | 8.3 | 7.4 | 6.2 |
Eli Lilly and Company Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 65,179,000,000.0 | 45,043,000,000.0 | 34,124,000,000.0 | 28,541,400,000.0 | — |
| Net Profit | 20,640,000,000.0 | 10,590,000,000.0 | 5,240,000,000.0 | 6,244,800,000.0 | — |
| EPS | 23.1 | 11.8 | 5.8 | 6.6 | — |
Eli Lilly and Company Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 112,476,000,000.0 | 78,715,000,000.0 | 64,006,300,000.0 | 49,489,800,000.0 | — |
| Total Liabilities | 85,941,000,000.0 | 64,443,000,000.0 | 53,142,600,000.0 | 38,714,400,000.0 | — |
| Total Equity | 26,535,000,000.0 | 14,272,000,000.0 | 10,771,900,000.0 | 10,649,800,000.0 | — |
Owes vs Owns
Eli Lilly and Company owed $0.76 for every $1 it owned in Jun 2026, down from $0.78 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.76× | 0.76× | 0.82× | 0.83× | 0.78× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Eli Lilly and Company Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 6.5%Receivables 17.9%Inventory 12.2%Fixed assets (tangible) 21.9%Intangible assets 11.0%Long-term investments 2.5%Other assets 27.9%
How it's funded — Dec 2025
Short-term debt 1.5%Long-term debt 36.3%Payables 4.8%Other liabilities 33.8%Shareholders' equity 23.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 7,268.0 | 3,268.0 | 2,927.7 | 2,211.8 |
| Receivables | 20,155.0 | 13,276.0 | 11,336.2 | 8,558.9 |
| Inventory | 13,744.0 | 7,589.0 | 5,772.8 | 4,309.7 |
| Fixed assets (tangible) | 24,674.0 | 17,103.0 | 12,913.6 | 10,144.0 |
| Intangible assets | 12,420.0 | 11,936.0 | 11,846.3 | 11,279.6 |
| Long-term investments | 2,802.0 | 3,216.0 | 3,052.2 | 2,901.8 |
| Other assets | 31,413.0 | 22,327.0 | 16,157.5 | 10,084.0 |
| Liabilities & equity | ||||
| Short-term debt | 1,635.0 | 5,117.0 | 6,904.5 | 1,501.1 |
| Long-term debt | 40,868.0 | 28,527.0 | 18,320.8 | 14,737.5 |
| Payables | 5,379.0 | 3,229.0 | 2,598.8 | 1,930.6 |
| Other liabilities | 38,059.0 | 27,570.0 | 25,318.5 | 20,545.2 |
| Shareholders' equity | 26,535.0 | 14,272.0 | 10,863.7 | 10,775.4 |
| Net tangible assets | 14,115.0 | 2,336.0 | -1,074.4 | -629.8 |
Eli Lilly and Company Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 16,813,000,000.0 | 8,818,000,000.0 | 4,240,000,000.0 | 7,585,700,000.0 | — |
| Investing Activities | -10,972,000,000.0 | -9,302,000,000.0 | -7,153,000,000.0 | -3,762,900,000.0 | — |
| Financing Activities | -2,213,000,000.0 | 1,230,000,000.0 | 3,496,000,000.0 | -5,406,700,000.0 | — |